|
Insider Trading: NABI BIOPHARMACEUTICALS
Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of NABI BIOPHARMACEUTICALS in the last 24 months are illustrated in figures 1 and 2. Table 1 shows the monthly insider trading data of NABI BIOPHARMACEUTICALS since year 2005. Table 2 shows the detailed insider transactions of NABI BIOPHARMACEUTICALS since 2005.
The reporting company's ticker symbol is NABI.
The reporting company's CIK number is 72444.
The total value of stock buying since 2005 is $6,181,357.
The total value of stock sales is $950,244.
The total value of stock exercises is $0.
1 year stock price chart,
1 day stock price chart
opopp opopopop
Figure 1. Monthly insider transaction values at NABI BIOPHARMACEUTICALS (NABI) in the past 24 months.
The trade values of insider stock buys, sales, and option exercises are in logarithmic scale
as shown on the right axis labels.
The detailed monthly and daily insider transactions are listed in the 2 tables below.
08 09 10 11 12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 -
Figure 2. Average prices of insider buys, sales, and option exercises at NABI BIOPHARMACEUTICALS (NABI) in the past 24 months. See table 2 for insider transaction details.
08 09 10 11 12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 -
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises
for NABI BIOPHARMACEUTICALS (NABI).
Trading Period
year-month |
Insider Buying
Shares Value ($) |
Insider Sales
Shares Value ($) |
Option Exercises
Shares Value ($) |
| 2008-04 | 0 | 0 | 120,000 | 489,025 | 0 | 0 |
| 2008-03 | 0 | 0 | 85,620 | 291,152 | 0 | 0 |
| 2007-05 | 1,140,000 | 5,921,200 | 0 | 0 | 0 | 0 |
| 2006-11 | 27,342 | 170,887 | 27,342 | 170,067 | 0 | 0 |
| 2005-11 | 15,000 | 52,800 | 0 | 0 | 0 | 0 |
| 2005-06 | 2,000 | 24,300 | 0 | 0 | 0 | 0 |
| 2005-05 | 1,000 | 12,170 | 0 | 0 | 0 | 0 |
Table 2. Detailed insider stock purchases, sales, and option exercises
for NABI BIOPHARMACEUTICALS (NABI)
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2008-04-03 | Hudson Leslie (Director) | Sale | 72,000 | 4.08 | 293,415 |
| 2008-03-10 | Siegel Jordan I (Sr. VP Fin. & Admin, CFO Treas) | Sale | 67,500 | 3.30 | 222,773 |
| 2008-03-05 | Kessler Paul D. (SVP Clinical, Med. & Reg.; CMO) | Sale | 3,120 | 3.75 | 11,689 |
| 2008-03-05 | Siegel Jordan I (Sr. VP Fin. & Admin, CFO Treas) | Sale | 7,500 | 3.80 | 28,464 |
| 2008-03-05 | Fahim Raafat E F (President and CEO) | Sale | 7,500 | 3.76 | 28,226 |
| 2007-05-10 | Loeb Daniel S (Other) | Purchase | 335,000 | 5.25 | 1,758,750 |
| 2007-05-09 | Loeb Daniel S (Other) | Purchase | 225,000 | 5.25 | 1,181,250 |
| 2007-05-08 | Loeb Daniel S (Other) | Purchase | 580,000 | 5.14 | 2,981,200 |
| 2006-11-03 | Loeb Daniel S (Other) | Purchase | 27,342 | 6.25 | 170,887 |
| 2006-11-03 | Loeb Daniel S (Other) | Sale | 27,342 | 6.22 | 170,067 |
| 2005-11-04 | Jooste H Le Roux (Mktng.) | Purchase | 10,000 | 3.55 | 35,500 |
| 2005-11-03 | Fahim Raafat E F (Prod.) | Purchase | 5,000 | 3.46 | 17,300 |
| 2005-06-08 | Fahim Raafat E F (Prod.) | Purchase | 2,000 | 12.15 | 24,300 |
| 2005-05-20 | Fahim Raafat E F (Prod.) | Purchase | 1,000 | 12.17 | 12,170 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of NABI BIOPHARMACEUTICALS (symbol NABI,
CIK number 72444) see
the Securities and Exchange Commission (SEC) website.
|
|
